Milton L Greenberg is a notable inventor based in Costa Mesa, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of CRAC channels. His innovative work has led to the development of compounds that have potential therapeutic applications.

Latest Patents

Milton holds 1 patent that describes compounds capable of modulating the activity of CRAC channels. The patent outlines methods for creating these compounds, as well as pharmaceutical compositions and medicaments that incorporate them. Furthermore, it details methods for using these compounds in the treatment of various conditions, diseases, or disorders associated with CRAC channel activity.

Career Highlights

Milton is currently associated with Vivreon Biosciences, LLC, where he continues to advance his research and development efforts. His work at Vivreon focuses on innovative solutions in the pharmaceutical industry, particularly in the area of channel modulation.

Collaborations

Milton has collaborated with notable professionals in his field, including Clayton A White and Andrew Newman. These collaborations have further enriched his research and contributed to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Milton L Greenberg is a distinguished inventor whose work in CRAC channel modulation has the potential to impact the treatment of various medical conditions. His contributions to the field exemplify the importance of innovation in pharmaceutical sciences.

Profile summary based on public USPTO records.